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Abstract
Background: Latent tuberculosis infection (LTBI) prevalence in the United States decreased approximately 60% in
the three decades between the 1971-1972 and 1999-2000 National Health and Nutrition Examination Survey
(NHANES) surveys. We examined the effects of birth cohort on LTBI prevalence over time.
Methods: Using weighted data analysis software to account for NHANES survey design, we calculated the
difference in LTBI prevalence between 1971-1972 and 1999-2000 for birth cohorts corresponding to 5-year intervals
(1912-1916, 1917-1921,1922-1926, 1927-1931, 1932-1936, 1937-1941, 1942-1946).
Results: LTBI prevalence was significantly lower in 1999-2000 compared to 1971-1972 for cohorts born in 1926 or
earlier (19% versus 5%), but not for cohorts born 1927-1946 (9% versus 7%). Adjustment for cohort restriction and
foreign-birth did not qualitatively change the results.
Conclusions: Although older age groups have higher rates of TB infection than younger groups, nationally
representative U.S. survey data suggest that observed LTBI prevalence in older people represents an underestimate
of infection, because of the birth cohort effect and waning immunologic reactivity.
Background
Two recent publications [1,2] estimate latent tuberculo-
sis infection (LTBI) prevalence in the United States
using the 1971-1972 and 1999-2000 National Health
and Nutrition Examination Survey (NHANES) data.
These studies show that LTBI prevalence has decreased
approximately 60% in the three decades between the
two surveys. Older age was associated with higher LTBI
prevalence in both NHANES time periods; however,
neither study examined LTBI in the same birth cohorts
over time. Therefore, we compared NHANES 1971-1972
data with NHANES 1999-2000 data to examine the
specific effects of birth cohort on LTBI prevalence.
Methods
Cohorts corresponding to birth years were constructed
in 5-year intervals (1912-1916, 1917-1921,1922-1926,
1927-1931, 1932-1936, 1937-1941, 1942-1946) based on
available 1971-1972 and 1999-2000 NHANES data by
age. Only people age 25-74 years old were offered
tuberculin skin testing (TST) in 1971-1972; all indivi-
duals 1 year of age and older were tested in 1999-2000.
The 1999-2000 data were available only with top-coded
age values such that all persons above age 85 were listed
as age 85. Thus, we could not report comparisons for
people born before 1912, and the comparison for people
who in 1971-1972 were age 55-59 years (1912-1916
birth cohort) includes in 1999-2000 all people age 83 or
older (born in 1916 or earlier). We report data by birth
cohort years and corresponding ages.
Our outcome was LTBI prevalence based on TST posi-
tivity, defined as an induration of 10 mm or greater in
reaction to purified protein derivative S-1. The protocol
for the tuberculosis component of the NHANES was
reviewed and approved by the NHANES institutional
review board. We analyzed data using SUDAAN 9.0 (RTI
International, Research Triangle Park, NC) and SAS 9.1
(SAS Institute, Cary, NC) software to account for
NHANES sample survey design and weighting. In brief,
we used NHANES Medical Examination Center sample
weights to estimate prevalence proportions while account-
ing for unequal selection and interview and physical
examination probabilities. We adjusted for TST non-
participation according to methods of Bennett et al. [1].
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ence in prevalence estimates between 1971-1972 and
1999-2000 for each cohort. We used sample variances
d e r i v e df r o mw e i g h t e dd a t at oc a l c u l a t e9 5 %c o n f i -
dence intervals (CI) around prevalence estimates and
around prevalence differences. Prevalence differences
comparing 1999-2000 with 1971-1972 estimates were
considered statistically significant if the 95% CI
excluded 0.
Results
Latent TB infection prevalence by birth cohort
In 1971-1972 NHANES data, 1012 adults were born
between 1912-1946 out of 1492 adults age 25-74 years
with a TST result. Out of 7386 persons with a TST
result in the 1999-2000 NHANES, 1710 adults were
born before 1947.
Figure 1 displays LTBI prevalence estimates and
associated 95% CI by birth cohort years and NHANES
sample year. For cohorts with members born in 1926 or
earlier, LTBI prevalence was significantly lower in
1999-2000 compared to 1971-1972. For those born in
1926 and earlier, the overall prevalence of LTBI was
19% in 1971-1972 versus 5% in 1999-2000, representing
greater than a three-fold decline. Prevalence differences
between NHANES periods were not significantly differ-
ent for cohorts with members who were 25-44 years
old in 1971-1972 (born 1927-1946). For those born
1927-1946, overall LTBI prevalence was 9% in 1971-
1972 compared to 7% in 1999-2000. Detailed cohort
data are shown in Table 1.
Assessment of prevalence bias
To assess potential bias due to cohort restriction, we
compared LTBI prevalence of the overall NHANES
populations tested to persons eligible for our analysis.
Including older persons (born before 1912) in the
1971-1972 population yielded nominally higher LTBI
estimates than our cohort eligible population, while
including younger persons (born after 1946) in 1999-
2000 resulted in slightly lower LTBI estimates than our
cohort analysis (Table 1).
To account for potential confounding by country of
origin, we repeated the analyses among 946 of 1012
(93%) persons in 1971-1972 and 1336 of 1710 (78%)
persons in 1999-2000 who were U.S.-born. Results were
within 2-3 percentage points of LTBI prevalence differ-
ence estimates for the combined U.S. and foreign-born
population, with the equivalent conclusion: LTBI preva-
lence in 1999-2000 was significantly lower than in 1971-
1972, achieving statistical significance among cohorts
born in 1926 or earlier (Figure 2). Data for foreign-born
individuals were too sparse for meaningful stratified
analysis: five of seven foreign-born cohorts in 1999-2000
contained fewer than five individuals who were LTBI
positive; all 95% confidence intervals were greater than
50 percentage points wide.
Discussion
When comparing 1971-1972 with 1999-2000 NHANES
data, we found a significant decline in LTBI prevalence
among people born before 1926 but not for younger
birth cohorts. Differences in LTBI prevalence in a birth
cohort over time are a balance between new infections
and waning of immunologic response to previous infec-
tions [3,4]. Our data suggest that for older birth cohorts,
the balance is in favor of waning response to previous
infections. For younger birth cohorts, the acquisition of
new infections may tip the balance in the other
direction.
Loss of immunologic reactivity to Mycobacterium
tuberculosis in humans can be demonstrated by “two-
step testing” with purified protein derivative (PPD), such
as during repeated screening of healthcare workers. Peo-
ple who test negative in response to the first PPD test
and subsequently test positive after a second test within
a short period of time (~ 2 weeks) are thought to repre-
sent immunologic boosting of a previous infection [3].
Some studies have reported that PPD boosting is asso-
ciated with age. Among hospital workers in Saudi Ara-
bia, immunologic boosting was more common among
workers over the age of 45 than younger workers [5].
Similarly, boosting was more than three times as com-
mon in employees 45 years and older than younger
employees in a study of 10 hospitals throughout the




























































Figure 1 Latent tuberculosis infection prevalence by birth
cohort and sample year. * National Health and Nutrition
Examination Survey 1999-2000 data were top-coded such that all
people age 85 and older were identified as 85. Thus the 1912-1916
cohort as analyzed using 1999-2000 data may include persons born
in earlier years.
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an association between boosting and age [7]. Perhaps
waning reactivity to PPD is not observable before a cer-
tain age, such as 45 years.
A potential limitation of our analysis is that LTBI pre-
valence estimates were based on reaction to PPD S-1,
which could include false-positive results based on reac-
tivity to nontuberculous mycobacteria (NTM) or bacillus
Calmette-Guérin (BCG) vaccination [8,9], An alternate
definition of LTBI incorporating results for PPD-Battey
in addition to PPD S-1 to assess NTM cross-reactivity
yielded no significant differences in prevalence estimates
compared with LTBI based on PPD S-1 alone [1].
Furthermore, the 1999-2000 NHANES reported a higher
prevalence of NTM sensitization compared with the
1971-1972 NHANES, and this difference was significant
among foreign-born persons [10]. Increases over time in
reactivity to NTM would increase LTBI prevalence esti-
mates, rather than contribute to decreases in LTBI that
Table 1 Latent tuberculosis infection prevalence by birth cohort and sample year















1942-1946 25-29 53-57 5.05%* 8.34% 3.29 -3.29 9.87
(no. = 129) (no. = 245)
1937-1941 30-34 58-62 7.30%* 5.28%* -2.01 -9.64 5.61
(no. = 123) (no. = 293)
1932-1936 35-39 63-67 8.97%* 4.70% -4.26 -10.23 1.70
(no. = 130) (no. = 321)
1927-1931 40-44 68-72 16.78% 8.51%* -8.27 -18.84 2.31
(no. = 110) (no. = 270)
1922-1926 45-49 73-77 19.47% 7.06% -12.41 -19.25 -5.57
(no. = 179) (no. = 217)
1917-1921 50-54 78-82 22.29% 2.71%* -19.58 -29.18 -9.98
(no. = 191) (no. = 214)
1912-1916
† 55-59 83-85+ 16.05% 3.60%* -12.46 -18.79 -6.12
(no. = 150) (no. = 150)
Selection bias analysis comparing ages available in 1971-1972 vs. 1999-2000
1912-1946
† TOTAL of cohorts TOTAL of cohorts 13.47% 6.25% -7.22 -3.31 -11.12
25-59 53-85+
(no. = 1012) (no. = 1710)
Not
applicable
TOTAL population TOTAL population 14.25% 5.70% -8.55 -5.067 -12.04
25-74 25-74







14.25% 4.18% -10.07 -6.68 -13.46
25-74 1-85+
(no. = 1492) (no. = 7386)
* Estimates are unstable because there are too few individuals represented in these subgroups.
† National Health and Nutrition Examination Survey 1999-2000 data were top-coded such that all people age 85 and older were identified as 85. Thus the
1912-1916 cohort as analyzed using 1999-2000 data may include persons born in earlier years.
Figure 2 Latent tuberculosis infection prevalence by birth
cohort and sample year, U.S.-born individuals. * National Health
and Nutrition Examination Survey 1999-2000 data were top-coded
such that all people age 85 and older were identified as 85. Thus
the 1912-1916 cohort as analyzed using 1999-2000 data may
include persons born in earlier years.
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nation is not likely to bias our findings. Prevalence esti-
mates considering foreign-born individuals with a BCG
scar as not having LTBI did not differ from estimates
ignoring BCG scars [1]; moreover, the NHANES for-
eign-born population was larger in 1999-2000 than
1971-1972, thus, potential misclassification due to BCG
would result in higher, rather than lower, LTBI esti-
mates in 1999-2000. Nonetheless, future research on
LTBI will benefit from newer diagnostic technologies
with higher specificity for M. tuberculosis,s u c ha si n t e r -
feron gamma release assays[11]. We did not analyze
data separately for persons who had ever been pre-
scribed treatment for TB or LTBI since this group
represented only 1.3% of the total population in 1999-
2000 NHANES [1,2].
The reduced LTBI prevalence among earlier birth
cohorts that we observed could be influenced by selec-
tive mortality, to the degree to which people with LTBI
progress to TB disease and die from TB or comorbid
conditions. Since LTBI is more prevalent among vulner-
able populations [1], people with high rates of LTBI in
earlier birth cohorts may experience higher mortality,
resulting in lower LTBI rates among survivors. We can-
not directly evaluate the influence of self-cure of TB,
waning immunity, or selective mortality, since we com-
pared birth cohorts across NHANES sample years,
rather than longitudinal follow-up of the same indivi-
duals over time. Another limitation was small sample
size in some cells, which restricted our ability to stratify
analyses. Finally, data were not available for a detailed
analysis of people born before 1912 or after 1946. How-
ever, comparison of LTBI prevalence – a relatively rare
outcome – is strengthened by our use of large, nation-
ally representative samples with consistent TST proto-
cols. NHANES household sampling mitigates potential
bias, in that the most vulnerable populations for LTBI
(homeless or incarcerated people, and residents of long-
term care facilities) are excluded. Importantly, our find-
ings did not appear to be driven by greater inclusion of
foreign-born people in 1999-2000 NHANES, as results
were similar when restricted to the U.S.-born.
Conclusions
Our study is the first that we are aware of to describe
t h ec h a n g ei nL T B Ip r e v a l e n c ea s s o c i a t e dw i t ha g ei n
relationship to the effects of birth cohort, as previously
described with respect to TB disease [12]. Although pre-
vious studies have shown that older age groups have
higher rates of TB infection than younger groups, our
nationally representative data suggest that observed
LTBI prevalence in older people represents an underes-
timate of infection, because of the birth cohort effect
and waning immunologic reactivity.
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